Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system-Reference-Cited by-同舟云学术

Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system

Author:

Kramer J. R.¹²^ORCID,Puenpatom A.³,Erickson K. F.¹²,Cao Y.¹,Smith D.¹,El-Serag H. B.¹²,Kanwal F.¹²

Affiliation:

1. Center for Innovations in Quality; Effectiveness, and Safety (IQuESt); Michael E. DeBakey VA Medical Center (MEDVAMC); Houston TX USA

2. Department of Medicine; Baylor College of Medicine; Houston TX USA

3. Merck & Co., Inc.; Kenilworth NJ USA

Funder

U.S. Department of Veterans Affairs

Veterans Health Administration

Office of Research and Development Service

National Institutes of Health

Merck & & Co., Inc., Kenilworth, NJ

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

Reference38 articles.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01